Gujarat Inject Q1 net profit jumps to ₹125.16 lakh on solar module trading
Revenue quintupled to ₹1,245.45 lakh as the company delivers on the ₹14.49 cr solar order landed in June. The trajectory was already visible in prior quarters.
— 8 earlier stories on Gujarat Inject (Kerala) Ltd. →What's new
- Revenue hit ₹1,245.45 lakh, more than five times the ₹242.12 lakh in Q1 FY26.
- Net profit rose to ₹125.16 lakh from ₹7.35 lakh.
- Results were flagged as standard, no surprise given prior order disclosures.
Why this matters
The solar-module trading bet is paying off in numbers, but the market cap already reflects the shift. The real test is whether the company can sustain this revenue level without the order book growing.
What we're watching
- Next order wins, as current run-rate depends on lumpy solar contracts.
- Q2 FY27 revenue to see if the pace holds post the Deon Energy delivery.
- Management commentary on the shelf-life of the trading business.
The full read
Gujarat Inject's Q1 FY27 numbers look spectacular at first glance: revenue of ₹1,245.45 lakh, more than five times last year's ₹242.12 lakh, and net profit of ₹125.16 lakh versus ₹7.35 lakh. The engine is solar module trading, driven by a ₹14.49 cr order from Deon Energy announced in June. But the market already knew this was coming. The company had telegraphed the revenue ramp in its Q4 FY26 results and the order disclosure. The filing is a confirmation, not a revelation. At a market cap of ₹180 cr, the trailing P/E is 99x. The open question is whether the order book has more such contracts to keep the momentum going, or if Q1 was the peak of a lumpy cycle. The results are constructive, but the easy money has been made on the news.
Questions answered
- What drove the massive revenue jump?
- The ramp-up in solar module trading, including a ₹14.49 cr order from Deon Energy announced in June 2026. Q1 revenue of ₹1,245.45 lakh reflects execution of that order.
- Is this level of profitability sustainable?
- The net profit margin is about 10% in Q1 (₹125.16 lakh on ₹1,245.45 lakh revenue). Sustainability depends on maintaining order flow and margins in the competitive solar trading space.
- How does this compare to the prior quarter (Mar 2026)?
- Mar 2026 revenue was ₹31 cr and net profit ₹2 cr. Q1 FY27 revenue of ₹12.45 cr is lower, but net profit of ₹1.25 cr is about 63% of the prior quarter's ₹2 cr, indicating a higher margin.
- Why did the analyst call this a 'standard' filing?
- The growth trajectory was already flagged in Q4 FY26 results and the June 11 order announcement. Q1 merely confirmed the execution without providing new surprises.
Gujarat Inject (Kerala) Ltd.
Latest quarter · Jun 2026
Strength & growth
Story so far
All notes on GUJINJEC →- 15 Jul 2026 · 10:04 AM IST Gujarat Inject Q1 net profit jumps to ₹125.16 lakh on solar module trading
- 7d ago Gujarat Inject Q1 net profit rises to ₹1.25 crore on solar trading
- 7d ago Gujarat Inject Q1 net profit jumps to ₹125.16 lakh on solar trading
- 16d ago Gujarat Inject fills top post after chairman's death, but new MD is from plastics
- 28d ago Gujarat Inject loses Chairman, CFO & Whole-Time Director in single death